Cargando…

Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway

This study investigated the effect of acylated synthetic ghrelin (AG) on the survival and proliferation of human chemosensitive ovarian cancer cells (A2780) and explored some mechanisms of action with a focus on the p53 apoptotic pathway and PI3K/Akt and NF-κB survival pathways. Human A2780 ovarian...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-kott, Attalla Farag, Shati, Ali A., Al-kahtani, Mohammed Ali, Alqahtani, Sultan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644235/ https://www.ncbi.nlm.nih.gov/pubmed/31360627 http://dx.doi.org/10.1155/2019/9627810

Ejemplares similares

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
por: Westhoff, Mike-Andrew, et al.
Publicado: (2013)

Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling
por: Yang, Lin, et al.
Publicado: (2023)

Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling
por: Zhang, Jinyu, et al.
Publicado: (2020)

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway
por: Jiang, Shaoyan, et al.
Publicado: (2019)

Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors
por: Melick, Chase H., et al.
Publicado: (2020)

Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin
por: Martins, Luís, et al.
Publicado: (2012)

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT
por: Baldanzi, Gianluca, et al.
Publicado: (2002)

Effect of BRAF-mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells
por: Ren, Bingnan, et al.
Publicado: (2021)

Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells
por: Lan, Chieh-Yu, et al.
Publicado: (2019)

Ghrelin O-Acyl Transferase: Bridging Ghrelin and Energy Homeostasis
por: Shlimun, Andrew, et al.
Publicado: (2011)

Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis
por: Feng, Feifei, et al.
Publicado: (2019)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023)

Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies
por: Costa, Anna-Maria, et al.
Publicado: (2022)

mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters
por: Liu, Yuanhui, et al.
Publicado: (2022)

Antifibrotic Activity of Acylated and Unacylated Ghrelin
por: Angelino, Elia, et al.
Publicado: (2015)

Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition
por: Michalopoulou, Evdokia, et al.
Publicado: (2020)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

Ghrelin, Des-Acyl Ghrelin, and Obestatin: Regulatory Roles on the Gastrointestinal Motility
por: Fujimiya, Mineko, et al.
Publicado: (2010)

β-Oxidation in ghrelin-producing cells is important for ghrelin acyl-modification
por: Ikenoya, Chika, et al.
Publicado: (2018)

Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway
por: Lin, Qiongyan, et al.
Publicado: (2017)

EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway
por: Huang, Rui, et al.
Publicado: (2018)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Both Acyl and Des-Acyl Ghrelin Regulate Adiposity and Glucose Metabolism via Central Nervous System Ghrelin Receptors
por: Heppner, Kristy M., et al.
Publicado: (2014)

Targeting PI3K/Akt/mTOR Signaling in Cancer
por: Porta, Camillo, et al.
Publicado: (2014)

PI3K/Akt/mTOR inhibitors in breast cancer
por: Lee, Joycelyn JX, et al.
Publicado: (2015)

Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway
por: Song, Qiang, et al.
Publicado: (2023)

Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin
por: Wenthur, Cody J., et al.
Publicado: (2019)

Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
por: El-Sheikh, Marwa, et al.
Publicado: (2023)

Acylated Ghrelin and The Regulation of Lipid Metabolism in The Intestine
por: Auclair, N., et al.
Publicado: (2019)

Use of Arctium lappa Extract Against Acetaminophen-Induced Hepatotoxicity in Rats
por: El-Kott, Attalla Farag, et al.
Publicado: (2015)

CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5‐FU‐induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway
por: Sun, Yi, et al.
Publicado: (2017)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
por: Sacco, Antonio, et al.
Publicado: (2010)

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
por: Markman, Ben, et al.
Publicado: (2010)

AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
por: Bhatt, Aadra P., et al.
Publicado: (2013)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
por: Matsuoka, Tasuku, et al.
Publicado: (2014)

Targeting the PI3K-AKT-mTOR signaling network in cancer
por: Khan, Khurum H., et al.
Publicado: (2013)

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
por: Fransecky, Lars, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8omk62icli3rjeimnpd27mbi1j